The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Long-term Results of Stellate Ganglion Block in Patients with Olfactory Dysfunction

  • Moon, Ho Sik (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Chon, Jin Young (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Lee, Sang Hoon (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Ju, Yu Mi (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Sung, Choon Ho (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea)
  • Received : 2012.10.09
  • Accepted : 2012.12.21
  • Published : 2013.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Olfactory dysfunction, including anosmia and hyposmia is difficult to treat. Although the mechanism is not well known, stellate ganglion block (SGB) is used to treat olfactory dysfunction. There are no prior studies on the long-term effects of SGB on olfactory dysfunction. The purpose of this study was to evaluate the continuity of therapeutic effects and patient satisfaction with SGB treatment. Methods: This was a follow-up study carried out via a telephonic survey. The olfactory function of the patient was evaluated using a visual analog scale (VAS). We checked VAS three times: VAS-I (pre-treatment VAS), VAS-A (post-treatment VAS), and VAS-C (VAS at follow up telephone survey). We divided the subjects into 2 groups according to their responsiveness to SGB: the responsive (R group) and the unresponsive groups (UR group). Patient satisfaction was evaluated using a Likert scale. Results: Out of the 40 subjects, 37 responded to the telephone survey. In the UR group, there was difference in the olfactory function. However, in the R group, there were significant VAS differences; VAS-I was $9.6{\pm}0.7$, VAS-A was $5.1{\pm}4.2$, and VAS-C was $2.7{\pm}$2.7 (P < 0.05). On the Likert scale, patient satisfaction was as follows: grade 1, 17 patients (45.9%); grade 2, 6 patients (16.2%); grade 3, 6 patients (16.2%); and grade 4, 8 patients (21.6%). Conclusions: SGB is a safe, long-lasting, and effective therapeutic modality for olfactory dysfunction treatment.

Keywords

References

  1. Schiffman SS. Taste and smell losses in normal aging and disease. JAMA 1997; 278: 1357-62. https://doi.org/10.1001/jama.1997.03550160077042
  2. Gaines AD. Anosmia and hyposmia. Allergy Asthma Proc 2010; 31: 185-9. https://doi.org/10.2500/aap.2010.31.3357
  3. Pignatelli A, Belluzzi O. Neurogenesis in the adult olfactory bulb. In: The neurobiology of olfaction. Edited by Menini A. Boca Raton (FL), CRC Press. 2010. Chapter 11. Available at http://www.ncbi.nlm.nih.gov/books/NBK55980/.
  4. Sivam A, Jeswani S, Reder L, Wang J, DeTineo M, Taxy J, et al. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy 2010; 24: 286-90. https://doi.org/10.2500/ajra.2010.24.3478
  5. Passàli GC, Ralli M, Galli J, Calò L, Paludetti G. How relevant is the impairment of smell for the quality of life in allergic rhinitis? Curr Opin Allergy Clin Immunol 2008; 8: 238-42. https://doi.org/10.1097/ACI.0b013e3282ffd6bb
  6. Schiffman SS. Taste and smell in disease (second of two parts). N Engl J Med 1983; 308: 1337-43. https://doi.org/10.1056/NEJM198306023082207
  7. Moon HS, Lee HJ, Sung CH, Lim SJ, Choi JH. The efficacy of stellate ganglion block in sensorineural anosmia patients unresponsive to steroid therapy. Korean J Pain 2007; 20: 154-7. https://doi.org/10.3344/kjp.2007.20.2.154
  8. Lee NS, Yoon HR, Park JW, Yum JH, Seo JH, Cho JH, et al. The efficacy of stellate ganglion block in olfactory disorder following upper respiratory tract infection. Korean J Otolaryngol- Head Neck Surg 2003; 46: 568-71.
  9. Bromley SM. Smell and taste disorders: a primary care approach. Am Fam Physician 2000; 61: 427-36.
  10. Hox V, Bobic S, Callebaux I, Jorissen M, Hellings PW. Nasal obstruction and smell impairment in nasal polyp disease: correlation between objective and subjective parameters. Rhinology 2010; 48: 426-32.
  11. Mullol J, Obando A, Pujols L, Alobid I. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin North Am 2009; 29: 657-68. https://doi.org/10.1016/j.iac.2009.07.001
  12. Curatolo M, Bogduk N. Diagnostic and therapeutic nerve blocks. In: Bonica's management of pain. 4th ed. Edited by Fishman SM, Ballantyne JC, Rathmell JP. Philadelphia, Lippincott Williams & Wilkins. 2010, pp 1401-23.
  13. Kakuyama M, Toda H, Osawa M, Fukuda K. The bilateral effect of stellate ganglion block on the facial skin blood flow. Reg Anesth Pain Med 2000; 25: 389-92. https://doi.org/10.1097/00115550-200007000-00012
  14. Reden J, Mueller A, Mueller C, Konstantinidis I, Frasnelli J, Landis BN, et al. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg 2006; 132: 265-9. https://doi.org/10.1001/archotol.132.3.265
  15. Kaplan MS, Hinds JW. Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. Science 1977; 197: 1092-4. https://doi.org/10.1126/science.887941
  16. Hack MA, Saghatelyan A, de Chevigny A, Pfeifer A, Ashery- Padan R, Lledo PM, et al. Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci 2005; 8: 865-72. https://doi.org/10.1038/nn1479
  17. Bordey A. Adult neurogenesis: basic concepts of signaling. Cell Cycle 2006; 5: 722-8. https://doi.org/10.4161/cc.5.7.2614
  18. Leuner B, Kozorovitskiy Y, Gross CG, Gould E. Diminished adult neurogenesis in the marmoset brain precedes old age. Proc Natl Acad Sci U S A 2007; 104: 17169-73. https://doi.org/10.1073/pnas.0708228104
  19. Rochefort C, Gheusi G, Vincent JD, Lledo PM. Enriched odor exposure increases the number of newborn neurons in the adult olfactory bulb and improves odor memory. J Neurosci 2002; 22: 2679-89.
  20. Huang L, Bittman EL. Olfactory bulb cells generated in adult male golden hamsters are specifically activated by exposure to estrous females. Horm Behav 2002; 41: 343-50. https://doi.org/10.1006/hbeh.2002.1767
  21. Hitoshi S, Maruta N, Higashi M, Kumar A, Kato N, Ikenaka K. Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress. J Neurosci Res 2007; 85: 3574-85. https://doi.org/10.1002/jnr.21455
  22. Doetsch F. A niche for adult neural stem cells. Curr Opin Genet Dev 2003; 13: 543-50. https://doi.org/10.1016/j.gde.2003.08.012
  23. Lee NS, Kim BG, Park JM, Park YS, Kim SW, Kim SW, et al. The effect of superior cervical ganglionectomy on recovery of olfaction in induced anosmic mice. Korean J Otolaryngol- Head Neck Surg 2005; 48: 1462-7.
  24. Yu HG, Chung H, Yoon TG, Yum KW, Kim HJ. Stellate ganglion block increases blood flow into the optic nerve head and the peripapillary retina in human. Auton Neurosci 2003; 109: 53-7. https://doi.org/10.1016/j.autneu.2003.08.010
  25. Takebayashi H, Tsuzuki K, Oka H, Fukazawa K, Daimon T, Sakagami M. Clinical availability of a self-administered odor questionnaire for patients with olfactory disorders. Auris Nasus Larynx 2011; 38:65-72. https://doi.org/10.1016/j.anl.2010.05.013
  26. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med 1988; 18: 1007-19. https://doi.org/10.1017/S0033291700009934

Cited by

  1. Relationship between Olfactory Dysfunction and Suicidal Ideation: The Korea National Health and Nutrition Examination Survey vol.29, pp.4, 2015, https://doi.org/10.2500/ajra.2015.29.4194
  2. Ultrasound Guided Stellate Ganglion Block in Postmastectomy Pain Syndrome: A Comparison of Ketamine versus Morphine as Adjuvant to Bupivacaine vol.2014, pp.None, 2013, https://doi.org/10.1155/2014/792569
  3. Stellate ganglion block reduces symptoms of Long COVID: A case series vol.362, pp.None, 2013, https://doi.org/10.1016/j.jneuroim.2021.577784